Mortimer Arthur
04-10

$Hims & Hers Health Inc.(HIMS)$ Hims is misperceived as a DTC pharmacy or telehealth app. In reality, it’s building a vertically integrated healthcare platform — combining software, clinical care, diagnostics, compounding, and fulfillment. This isn’t just about better margins — it’s about controlling the entire patient journey and creating a scalable, defensible infrastructure. (Moat)

Once the market recognizes Hims as a core layer of consumer healthcare infrastructure, not just a front-end, the valuation shifts. True platform companies with similar vertical integration and recurring models often trade at 10–20x revenue. That re-rating isn’t hype — it’s a function of business model strength and structural positioning.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment